Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Patient satisfaction following treatment with botulinum toxin type A: a systematic review

Patient satisfaction following treatment with botulinum toxin type A: a systematic review The objective of this research was to identify which factors most contributed to patient satisfaction following the treatment of facial lines with botulinum toxin type A. A systematic review was performed by the author, following the Joanna Briggs Institute's methodology, of studies that included data on patient satisfaction following injection of botulinum toxin type A to reduce appearance of facial lines. Seven studies were critically appraised, comprising 696 patients. A relationship between dose, clinical effect and duration of effect was observed, and it was found that lower doses were more likely to result in a decreased duration of action. Patient satisfaction results broadly peaked and declined in line with the timing of the pharmacological effect of botulinum toxin type A. Results suggested patients treated for glabellar lines may be more satisfied in comparison with those treated in the lateral canthus. This review looked at a limited number of parameters that were available for comparison from the current research. The findings have implications for the information patients are given ahead of treatment. More research is needed before adequate comparisons can be made between toxins and dilutions used. The adoption of a standardised assessment tool for botulinum toxin type A and dermal fillers would be useful. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Aesthetic Nursing Mark Allen Group

Patient satisfaction following treatment with botulinum toxin type A: a systematic review

Journal of Aesthetic Nursing , Volume 1 (2): 6 – Jul 1, 2012

Loading next page...
 
/lp/mark-allen-group/patient-satisfaction-following-treatment-with-botulinum-toxin-type-a-a-QrghTtg2TO
Publisher
Mark Allen Group
Copyright
Copyright © 2012 MA Healthcare Limited
ISSN
2050-3717
eISSN
2052-2878
DOI
10.12968/joan.2012.1.2.91
Publisher site
See Article on Publisher Site

Abstract

The objective of this research was to identify which factors most contributed to patient satisfaction following the treatment of facial lines with botulinum toxin type A. A systematic review was performed by the author, following the Joanna Briggs Institute's methodology, of studies that included data on patient satisfaction following injection of botulinum toxin type A to reduce appearance of facial lines. Seven studies were critically appraised, comprising 696 patients. A relationship between dose, clinical effect and duration of effect was observed, and it was found that lower doses were more likely to result in a decreased duration of action. Patient satisfaction results broadly peaked and declined in line with the timing of the pharmacological effect of botulinum toxin type A. Results suggested patients treated for glabellar lines may be more satisfied in comparison with those treated in the lateral canthus. This review looked at a limited number of parameters that were available for comparison from the current research. The findings have implications for the information patients are given ahead of treatment. More research is needed before adequate comparisons can be made between toxins and dilutions used. The adoption of a standardised assessment tool for botulinum toxin type A and dermal fillers would be useful.

Journal

Journal of Aesthetic NursingMark Allen Group

Published: Jul 1, 2012

There are no references for this article.